DUBLIN--(BUSINESS WIRE)--The "European Hemostats & Sealants Market by Brand (Hemopatch [Baxter], Tachosil [Takeda], Veriset [Medtronic], Avitene [C.R Bard], Sangustop [B Braun], Lyostypt [B Braun]), Country (Germany, Uk, France, Italy & Spain) - Forecast to 2024" report has been added to ResearchAndMarkets.com's offering.
European Hemostats and Sealants market to register a CAGR of 7% from 2019 to 2024
The European hemostats and sealants market is projected to reach USD 89 million by 2024 from USD 63 million in 2019, at a CAGR of 7% during the forecast period. Growth in this market is mainly driven by the increasing number of surgical procedures and the favorable reimbursement scenario in the European region.
Tachosil exhibited the highest CAGR over the forecast period
By brand, the hemostats and sealants market is segmented into Tachosil, Lyostypt, Sangustop, Veriset, Avitene, and Hemopatch. Over the forecast period, Tachosil accounted for the highest CAGR. The product provides effective results in emergency cases.
Germany exhibited the largest share in the market
Germany accounted for the largest share in the hemostats and sealants market. The large share of this market segment can be attributed to the larger patient population and surgical procedures.
Key Topics Covered
1. Introduction
2. Research Methodology
3. Executive Summary
4. Market Overview
4.1 Respondent Profile
4.2 Introduction
4.3 Market Dynamics
4.4 Sealing Products
5. Hemostats Market, By Product & Country
5.1 Sangustop
5.1.1 Germany
5.1.2 UK
5.1.3 France
5.1.4 Italy
5.1.5 Spain
5.2 Lyostypt
5.2.1 Germany
5.2.2 UK
5.2.3 France
5.2.4 Italy
5.2.5 Spain
5.3 Avitene
5.3.1 Germany
5.3.2 UK
5.3.3 France
5.3.4 Italy
5.3.5 Spain
5.4 Tachosil
5.4.1 Germany
5.4.2 UK
5.1.3 France
5.4.4 Italy
5.4.5 Spain
5.5 Hemopatch
5.5.1 Germany
5.5.2 UK
5.5.3 France
5.5.4 Italy
5.5.5 Spain
5.6 Veriset
5.6.1 Germany
5.6.2 UK
5.6.3 France
5.6.4 Italy
5.6.5 Spain
For more information about this report visit https://www.researchandmarkets.com/r/pfjq0x